These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J; Chen MH; Yang W; Wu W; Yan K Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144 [TBL] [Abstract][Full Text] [Related]
4. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach. Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442 [TBL] [Abstract][Full Text] [Related]
7. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H; J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960 [TBL] [Abstract][Full Text] [Related]
10. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma]. Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875 [TBL] [Abstract][Full Text] [Related]
11. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423 [TBL] [Abstract][Full Text] [Related]
13. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Mahnken AH; Bruners P; Günther RW Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers. Lin SM Chang Gung Med J; 2009; 32(1):22-32. PubMed ID: 19292936 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326 [TBL] [Abstract][Full Text] [Related]
16. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [TBL] [Abstract][Full Text] [Related]
19. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma]. Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886 [TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for unresectable tumors of the liver. Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]